Market Overview

2018 Primary Progressive Multiple Sclerosis (PPMS) Pipeline Insights - ResearchAndMarkets.com

Share:

The "Primary
Progressive Multiple Sclerosis (PPMS) - Pipeline Insight, 2018"

drug pipelines has been added to ResearchAndMarkets.com's
offering.

This report offers a comprehensive insight of the pipeline (under
development) therapeutics scenario and growth prospects across Primary
Progressive Multiple Sclerosis (PPMS) development.

The report provides detailed coverage of the pipeline landscape for this
mechanism of action, equipped with data from multiple sources with
complete pipeline analysis by developmental stage, associated
indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental
Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product
profiles including (but not limited to) drug description, product
development and R&D activities encompassing clinical and pre-clinical
studies, designations, collaborations, licensing deals, grants,
technologies and patent details.

The report assesses the active Primary Progressive Multiple Sclerosis
(PPMS) pipeline products by developmental stage, product type, molecule
type, and administration route.

Scope

  • The report provides a snapshot of the pipeline development for the
    Primary Progressive Multiple Sclerosis (PPMS)
  • The report covers pipeline activity across the complete product
    development cycle i.e. clinical, pre-clinical and discovery stages for
    the Primary Progressive Multiple Sclerosis (PPMS)
  • The report provides pipeline product profiles which includes product
    description, developmental activities, licensors & collaborators and
    chemical information
  • Provides pipeline assessment by monotherapy and combination therapy
    products, stage of development, route of administration, and molecule
    type for Primary Progressive Multiple Sclerosis (PPMS)
  • The report also covers the dormant and discontinued pipeline projects
    related to the Primary Progressive Multiple Sclerosis (PPMS)

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • Genzyme Corporation
  • Glialogix
  • Kyorin Pharmaceutical Co.
  • MedDay SA
  • Santhera Pharmaceuticals Holding AG
  • Teva Pharmaceutical Industries Ltd.

Key Topics Covered

1. Report Introduction

2. Primary Progressive Multiple Sclerosis (PPMS) Overview

3. Pipeline Therapeutics

4. Comparative Analysis

5. Products in Clinical Stage

6. Products in Pre-Clinical and Discovery Stage

7. Therapeutic Assessment

8. Inactive Products

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/dkchcz/2018_primary?w=4

View Comments and Join the Discussion!